Article
Improving Individualized Rhabdomyosarcoma Prognosis Predictions Using Somatic Molecular Biomarkers
2024-09-05
Abstract excerpt
<h4>Purpose</h4> Molecular markers, such as FOXO1 fusion genes and TP53 and MYOD1 mutations, increasingly influence risk-stratified treatment selection for pediatric rhabdomyosarcoma (RMS). This study aims to integrate molecular and clinical data to produce individualized prognosis predictions that can further improve treatment selection. <h4>Patients and Methods</h4> Clinical variables and somatic mutation data f...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 939eda7a-25c0-5be3-b0fd-e90ff0082a23
- DOI
- 10.1101/2024.09.04.24313032
